Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 5 49-5, 2004, Pages

  Stanley, Sarah ^a   Wynne, Katie ^a   Bloom, Steve ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; OXYNTOMODULIN; PANCREAS POLYPEPTIDE; PEPTIDE YY;

ANOREXIA; APPETITE DISORDER; BEHAVIOR; FEEDING BEHAVIOR; GASTROINTESTINAL TRACT FUNCTION; HUMAN; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SATIETY; SIGNAL TRANSDUCTION;

DIGESTIVE SYSTEM; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDES; HUMANS; OXYNTOMODULIN; PANCREATIC POLYPEPTIDE; PEPTIDE FRAGMENTS; PEPTIDE YY; PROTEIN PRECURSORS; SATIETY RESPONSE; SIGNAL TRANSDUCTION;

EID: 1942487860     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00536.2003     Document Type: Review

References (22)

1. Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, and Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124: 1325-1336, 2003.
2. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, and Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349: 941-948, 2003.
3. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, and Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
4. Batterham RL, Le Roux CW, Cohen MA, Park A, Ellis SM, Patterson M, Frost GS, Ghatei MA, and Bloom SR. Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab 88: 3989-3992, 2003.
5. Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, and Chance RE. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides 14: 497-503, 1993.
6. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, and Bloom SR. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 88: 4696-4701, 2003.
7. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, and Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25, Suppl 5: S63-S67, 2001.
8. Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, and Bloom SR. Oxyntomodalin inhibits food intake in the rat. Endocrinology 142: 4244-4250, 2001.
9. Ekblad E and Sundler F. Distribution of pancreatic polypeptide and peptide YY. Peptides 23: 251-261, 2002.
10. Hagan MM. Peptide YY: a key mediator of orexigenic behavior. Peptides 23: 377-382, 2002.
11. Katsuura G, Asakawa A, and Inui A. Roles of pancreatic polypeptide in regulation of food intake. Peptides 23: 323-329, 2002.
12. Kimmel JR, Hayden LJ, and Pollock HG. Isolation and characterization of a new pancreatic polypeptide hormone. J Biol Chem 250: 9369-9376, 1975.
13. Larhammar D. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65: 165-174, 1996.
14. Malaisse-Lagae F, Carpentier JL, Patel YC, Malaisse WJ, and Orci L. Pancreatic polypeptide: a possible role in the regulation of food intake in the mouse. Hypothesis Experientia 33: 915-917, 1977.
15. Meeran K, O'Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, Steere J, Choi SJ, Ghatei MA, and Bloom SR. Repeated intracerebro-ventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat. Endocrinology 140: 244-250, 1999.
16. Orskov C, Poulsen SS, Moller M, and Holst JJ. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45: 832-835, 1996.
17. Tatemoto, and Mutt K, V. Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides. Nature 285: 417-418, 1980.
18. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, and Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379: 69-72, 1996.
19. Ueno N, Inui A, Iwamoto M, Kaga T, Asakawa A, Okita M, Fujimiya M, Nakajima Y, Ohmoto Y, Ohnaka M, Nakaya Y, Miyazaki JI, and Kasuga M. Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology 117: 1427-1432, 1999.
20. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, Long SJ, Morgan LM, Holst JJ, and Astrup A. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86: 4382-4389, 2001.
21. Verdich C, Toubro S, Buemann B, Lysgard MJ, Juul HJ, and Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25: 1206-1214, 2001.
22. Zander M, Madsbad S, Madsen JL, and Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359: 824-830, 2002.